Professional
Added to YB: 2026-01-09
Pitch date: 2026-01-07
CLPT [neutral]
ClearPoint Neuro, Inc.
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
Market Cap
$422.1M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.02
P/E
-17.17
EV/Sales
12.22
Sector
Health Care Equipment and Supplies
Category
N/A
Pernas Research Passes On: ClearPoint Neuro, Inc.
CLPT (pass): MRI-guided neurosurgery tools w/ modest growth (HSD-low teens YoY). Slow adoption due to switching costs & retraining needs. Mgmt pivoting to gene therapy delivery platform but commercialization much further out than implied. Core imaging biz proven but growth insufficient to justify expansion assumptions.
Read full article (1 min)